Preferred Label : umirolimus;

MeSH note : sirolimus derivative from a biodegradable polylactic acid polymer; possesses enhanced anti-inflammatory and antiproliferative activity with an improved pharmacokinetic profile; structure in first source;

CISMeF synonym : Biolimus A9;

MeSH synonym : 42-O-(2-ethoxyethyl) rapamycin; rapamycin, 42-O-(2-ethoxyethyl)-; 40-O-(2-ethoxyethyl)rapamycin;

Is substance : O;

UNII : U36PGF65JH;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_1545470/fr/nobori-systeme-d-endoprothese-coronaire
http://www.has-sante.fr/portail/jcms/c_1545469/fr/nobori-23-avril-2013-4396-avis
2013
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
health technology assessment
sirolimus
umirolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1715363/fr/biomatrix
http://www.has-sante.fr/portail/jcms/c_1716081/fr/biomatrix
2013
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
sirolimus
umirolimus
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1715362/fr/biomatrix-flex
http://www.has-sante.fr/portail/jcms/c_1716084/fr/biomatrix-flex
2013
France
French
Drug-Eluting stents
coronary artery disease
sirolimus
umirolimus
health technology assessment
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1216621/nobori-21-fevrier-2012-4217-avis
http://www.has-sante.fr/portail/jcms/c_1231920/nobori-21-fevrier-2012-4217-avis
2012
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
sirolimus
umirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_703389/nobori
http://www.has-sante.fr/portail/jcms/c_703391/nobori-cepp-1784
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
sirolimus
umirolimus
health technology assessment
treatment outcome

---
Nous contacter.
02/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.